Marina O. Babikhina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marina O. Babikhina has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Anastasiia V. Shatilova
National Research Center – Institute of Immunology of the Federal Medical-Biological Agency, Moscow
3 shared publications - Dmitry Anatolievich Kudlay
Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia
3 shared publications - Musa Rakhimovich Khaitov
National Research Center Institute of Immunology FMBA of Russia Moscow Russian Federation
3 shared publications - Sergey M. Andreev
National Research Center – Institute of Immunology Federal Medical-Biological Agency of Russia
3 shared publications - Igor P. Shilovskiy
National Research Center Institute of Immunology Federal Medical-Biological Agency of Russia, 115522 Moscow, Russia
2 shared publications - Valery Valerieevich Smirnov
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
2 shared publications
Latest Publications
- Open Access
- 28 December 2024
- Published by Farmarus Print Media in Russian Journal of Allergy
- Vol. 21 (4) , 492-501
Ragweed pollen allergens: description and prospects for the development of new highly effective allergy vaccines
Ragweed pollen allergy is widespread in the South of Russia, the Far East and other regions, where 25 to 40 % of all weeds-allergic patients may be sensitized specifically to ragweed, representing an important public health problem. Drugs of various pharmacological groups used for the treatment of ragweed pollen allergy affect only the symptoms but not the cause of allergy. Existing pathogenetic therapy (allergen-specific immunotherapy with allergy vaccines based on water-salt extracts) requires long courses and can cause significant side effects. The development of more effective allergy vaccines requires the study of the structures of ragweed pollen allergens and the identification of their IgE epitopes. Based on these epitopes, new highly effective allergy vaccines can be developed using recombinant technologies that will lack the disadvantages of water-salt extracts and will possess the ability to enhance the induction of protective IgG. This review is focused on the epidemiology of ragweed pollen allergy, as well as the latest approaches to the analysis of its allergens’ structures and development of allergy vaccines. Presented information is relevant for the development of new promising highly effective allergy vaccines for allergen-specific immunotherapy of ragweed pollen allergy.
- 28 December 2024
- Published by Farmarus Print Media in Russian Journal of Allergy
- Vol. 21 (4) , 492-501
Open AccessRagweed pollen allergens: description and prospects for the development of new highly effective allergy vaccines
Ragweed pollen allergy is widespread in the South of Russia, the Far East and other regions, where 25 to 40 % of all weeds-allergic patients may be sensitized specifically to ragweed, representing an important public health problem. Drugs of various pharmacological groups used for the treatment of ragweed pollen allergy affect only the symptoms but not the cause of allergy. Existing pathogenetic therapy (allergen-specific immunotherapy with allergy vaccines based on water-salt extracts) requires long courses and can cause significant side effects. The development of more effective allergy vaccines requires the study of the structures of ragweed pollen allergens and the identification of their IgE epitopes. Based on these epitopes, new highly effective allergy vaccines can be developed using recombinant technologies that will lack the disadvantages of water-salt extracts and will possess the ability to enhance the induction of protective IgG. This review is focused on the epidemiology of ragweed pollen allergy, as well as the latest approaches to the analysis of its allergens’ structures and development of allergy vaccines. Presented information is relevant for the development of new promising highly effective allergy vaccines for allergen-specific immunotherapy of ragweed pollen allergy.
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 45 (2)
Novel synthetic antiviral peptides: design, synthesis, physico-chemical analysis and activity
Новые синтетические противовирусные пептиды. Проектирование, получение, физико-химический анализ, изучение активности
- 1 January 2024
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 45 (2)
Open AccessNovel synthetic antiviral peptides: design, synthesis, physico-chemical analysis and activity
Новые синтетические противовирусные пептиды. Проектирование, получение, физико-химический анализ, изучение активности
- 2 December 2023
- Published by Farmarus Print Media in Russian Journal of Allergy
- Vol. 20 (4) , 387-401
Cationic peptides as promising compounds for the treatment of bacterial complications in atopic dermatitis: Antibacterial activity assessment
BACKGROUND: The decrease in the effectiveness of antibiotics against the background of resistance of microorganisms aggravates the therapy of atopic dermatitis complicated by bacterial infection and actualizes the development of new antimicrobial agents. AIM: To develop, synthesize, and evaluate the antibacterial activity of cationic peptides and an aqueous solution of fullerene C60 to create drugs based on them that will have a spectrum of biological activity, including anti-inflammatory, antiallergic, and antibacterial activities. MATERIALS AND METHODS: This study analyzed the developed linear and dendrimer cationic peptides, whose structure was confirmed by matrix-assisted laser desorption ionization–time of flight mass spectrometry. An aqueous solution of fullerene C60 was obtained using a uniquely developed and patented technology. Antibacterial activity was assessed by diffusion into agar using disks (screening) and serial dilution, which was used to determine the minimum bactericidal concentration of the studied compounds. RESULTS: Moreover, 42 cationic peptides with various structures were developed and synthesized. The molecular weight of the peptides did not exceed 5,000 Da. They contained 7–25 amino acids with charges from +5 to +16. Screening was carried out through diffusion into agar using disks and revealed 15 peptides that showed activity against Escherichia coli Dh5a. Thus, using the method of counting colonies, the peptides AB-14, AB-17, and AB-18 showed bactericidal activity relative to E. coli Dh5a in concentrations of 0.03, 0.15, and 0.74 mM, respectively, which exceeded that of ampicillin (0.74 mM) several times. Analysis of an aqueous solution of fullerene C60 did not reveal its antibacterial activity. CONCLUSIONS: The antibacterial activity of the resulting peptides makes them promising for the development of antibacterial therapeutic agents.
- 2 December 2023
- Published by Farmarus Print Media in Russian Journal of Allergy
- Vol. 20 (4) , 387-401
Cationic peptides as promising compounds for the treatment of bacterial complications in atopic dermatitis: Antibacterial activity assessment
BACKGROUND: The decrease in the effectiveness of antibiotics against the background of resistance of microorganisms aggravates the therapy of atopic dermatitis complicated by bacterial infection and actualizes the development of new antimicrobial agents. AIM: To develop, synthesize, and evaluate the antibacterial activity of cationic peptides and an aqueous solution of fullerene C60 to create drugs based on them that will have a spectrum of biological activity, including anti-inflammatory, antiallergic, and antibacterial activities. MATERIALS AND METHODS: This study analyzed the developed linear and dendrimer cationic peptides, whose structure was confirmed by matrix-assisted laser desorption ionization–time of flight mass spectrometry. An aqueous solution of fullerene C60 was obtained using a uniquely developed and patented technology. Antibacterial activity was assessed by diffusion into agar using disks (screening) and serial dilution, which was used to determine the minimum bactericidal concentration of the studied compounds. RESULTS: Moreover, 42 cationic peptides with various structures were developed and synthesized. The molecular weight of the peptides did not exceed 5,000 Da. They contained 7–25 amino acids with charges from +5 to +16. Screening was carried out through diffusion into agar using disks and revealed 15 peptides that showed activity against Escherichia coli Dh5a. Thus, using the method of counting colonies, the peptides AB-14, AB-17, and AB-18 showed bactericidal activity relative to E. coli Dh5a in concentrations of 0.03, 0.15, and 0.74 mM, respectively, which exceeded that of ampicillin (0.74 mM) several times. Analysis of an aqueous solution of fullerene C60 did not reveal its antibacterial activity. CONCLUSIONS: The antibacterial activity of the resulting peptides makes them promising for the development of antibacterial therapeutic agents.